Kennedy has expressed skepticism about vaccines and drug usage, and his potential oversight of agencies like CDC, NIH, and FDA raises concerns. He also advocates for banning pharma direct-to-consumer advertising and leveling drug costs, which worries the industry.
Vaccine makers, obesity, and diabetes companies are particularly affected. Kennedy has questioned vaccine safety and criticized COVID-19 vaccines, and he is critical of obesity and diabetes drugs like Monjaro and Ozempic.
Smugglers are exploiting fears that Trump will implement a full border shutdown, making it impossible for migrants to enter the U.S. legally. They use social media and chat groups to share tips and encourage a pre-inauguration rush.
Authorities in Guatemala and Mexico are concerned about a surge, especially given the more sophisticated immigration enforcement under the Trump administration. They aim to prevent large-scale events that attract media attention and manage border security effectively.
Migrants fear that if legal pathways like CBP-1 appointments are dismantled, they will have little chance of entering the U.S. legally and may be immediately expelled back to Mexico, similar to the Title 42 policy during the pandemic.
P.M. Edition for Nov. 15. WSJ Latin America deputy editor Santiago Pérez) explains how smuggler warnings about President-elect Donald Trump could trigger a migration surge) at the U.S. border. And U.S. stocks fall after a Federal Reserve official indicates a December interest rate cut wasn’t a “done deal.”) Plus, Heard on the Street columnist David Wainer) on how Robert F. Kennedy Jr.’s health and human services secretary nomination is raising alarms among U.S. and European pharmaceutical companies). Tracie Hunte hosts.
Sign up for the WSJ's free What's News newsletter).
Learn more about your ad choices. Visit megaphone.fm/adchoices)